Search results

Aura Biosciences, Inc. (AURA) closed the last trading session at $7.29, gaining 11.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Chewy (CHWY) closed the last trading session at $27.52, gaining 17.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Shares of nCino (NCNO) have gained 21.5% over the past four weeks to close the last trading session at $18.46, but there could still be a solid upside left in the stock if short-term price targets

Abercrombie & Fitch (ANF) closed the last trading session at $94.36, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Draganfly Inc. (DPRO) closed the last trading session at $5.94, gaining 5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

ANI Pharmaceuticals ANIP has been steadier than its broader sector this year, but it has not fully kept pace with its closest peer set. Shares are up 2.5% year to date, versus a 3.5% gain for the

ANI Pharmaceuticals ANIP is reshaping its growth profile around specialty medicines, with Cortrophin Gel increasingly driving results and management’s 2026 targets. Fiscal 2025 also underscored how

Solaris Energy Infrastructure SEI is at a decision point near $65, with a 6–12 month price target of $70 that frames modest upside over the next year. That same 6–12 month outlook implies

Colliers International (CIGI) closed the last trading session at $117.75, gaining 15.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Progress Software (PRGS) closed the last trading session at $31.32, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Neurocrine Biosciences (NBIX) closed the last trading session at $131.59, gaining 3.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Stantec (STN) closed the last trading session at $91.94, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Pagaya Technologies PGY is showing a clearer earnings profile after a multi-quarter profitability turn, even as near-term volume remains intentionally constrained. The stock recently traded at

Shares of LendingClub (LC) have gained 19% over the past four weeks to close the last trading session at $17.39, but there could still be a solid upside left in the stock if short-term price targets

Shares of Teradata (TDC) have gained 5.4% over the past four weeks to close the last trading session at $27.51, but there could still be a solid upside left in the stock if short-term price targets

As life sciences companies increasingly shift toward targeted, AI-driven engagement, OptimizeRx OPRX’s ability to secure large enterprise deals and capitalize on med tech momentum could be decisive

Kimbell Royalty (KRP) closed the last trading session at $14.54, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Reddit Inc. (RDDT) closed the last trading session at $164.31, gaining 17.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Black Diamond Therapeutics BDTX is a clinical-stage oncology company with a story that is simple and high stakes. The upside case is tied to one drug, silevertinib, and the market’s willingness to

In the fourth quarter of 2025, Auna S.A. AUNA saw its adjusted EBITDA decline 14% in FX neutral, with the margin contracting 4.5 percentage points to 19.5%. Performance of all segments was mixed